Sign in

CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company

Adaptimmune Therapeutics PLC

Sign in to watch
Ticker
ADAPY
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
United Kingdom
Entity type
operating
Phone
44 1235 430000
Business address
60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
Former names
Adaptimmune Ltd
  1. 4 Open-market sale Chief Patient Supply Officer sold 4,823 shares at $9.25 ($44,613)
  2. 4 Open-market sale Chief Business Officer sold 200,000 shares at $8.74 ($1,748,180)
  3. 4 Open-market sale Chief Executive Officer sold 2,788 shares at $9.25 ($25,789)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market buy Chief Financial Officer bought 33,000 shares at $1.62 ($53,460)
  13. 4 Open-market buy Director bought 12,900 shares at $1.89 ($24,381)
  14. 4 Open-market sale Director sold 500,000 shares at $9.33 ($4,666,000)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 4 Open-market buy 10% owner bought 7,500,000 shares at $0.67 ($5,000,250)
  19. 4 Open-market buy 10% owner bought 7,500,000 shares at $0.67 ($5,000,250)
  20. 4 Open-market buy Director bought 7,500,000 shares at $0.67 ($5,000,250)

Page 9 of 18 · 351 filings